World-class speaker lineup announced for Virtual Biopharmaceutical Summit 2021
Register free today to join scientists from around the world as they come together to discuss the hottest topics and latest technology solutions
7 Oct 2021
The first tranche of top speakers has been announced for the SelectScience® Virtual Biopharmaceuticals Summit 2021, launching on Tuesday, November 9.
Featuring major new developments in biopharmaceutical research, from cutting-edge technologies to novel techniques and top resources to advance your work, the free-to-attend Virtual Summit will offer scientists and scientific manufacturers an interactive forum to connect and share knowledge and solutions at this critical time.
Following the success of last year's inaugural Biopharmaceuticals Summit, the 2021 event promises to be even bigger and better than ever, with top speakers lined up and an array of new features including a product launch booth showcasing the latest innovations and an attendee search facility to enhance your networking opportunities.
Free early bird registration is now available — register now to access expert presentations by leading scientists and technology providers, live Q&As, interactive booths, new product launches, networking sessions, 1-on-1 chat facilities, and more.
Register hereHeadline topics will include cell and gene therapy, biopharmaceutical characterization, nanomedicines, and much more.
We are delighted to announce our first confirmed speakers, with more to follow imminently:
- Dr. Gerhard Bauer, University of California Davis: Focuses on gene therapy and CAR-T cell research and has also helped develop a treatment for HIV
- Dr. Lewis Francis, Swansea University: Focuses on nanomedicines in the gynecological space
- Dr. Andrew Mahan, The Janssen Pharmaceutical Companies of Johnson & Johnson: Focuses on end to end automation of biotherapeutic MS characterization
- Dr. Jared Auclair, Northeastern University: Focuses on biopharmaceutical development and analysis
- Christine Probst, KBI Biopharma: Focuses on machine learning applications for the characterization of particle profiles of therapeutic products
- Dr. John Kellie, GSK: Will discuss advanced protein LC-MS as a characterization tool for bioanalysis
- Prof. Christian Adam Olsen, University of Copenhagen: Studies macrocyclic peptides for development of HDAC inhibitors and quorum sensing modulators
- Bjørn Gunnar Voldborg, Technical University of Denmark: Focuses on optimizing protein expression: glycosylation, titer and development
Why attend?
- Keep up with cutting-edge research from world-class speakers
- Learn about the latest technology launches
- Ask the experts - live Q&As with manufacturers and scientists
- Collect a ‘swag bag’ of application notes, posters, technical papers, and other key resources
- Network with scientists, globally
Would you, or your lab, like to share your latest biopharmaceutical research with a global audience of scientists? We’re introducing a new poster hall feature at the Summit, but be quick, the deadline for submissions is Monday, October 11:
- Deadline for abstract submission: October 11, 2021
- Notifications of acceptance sent to presenting author(s): October 15, 2021
- Deadline for virtual poster submission: October 29, 2021
Suggested topics include cell and gene therapy, QA/QC, COVID-19, biopharma characterization, liquid biopsy, antibody engineering, microbiome, biomarkers, biobanking, bioprocessing and manufacturing
By completing your submission, you will also be given free access to the Summit.
For further updates, follow our social media channels:
Catch up on the latest techniques and technologies and play your part in improving science communication by leaving a lab product review for a chance to win a $400 Amazon Gift Card.
Spread the word using #BiopharmaSummit
Manufacturers should contact salesteam@selectscience.net today for further information or to book booth space.